On Friday, in the course of current trade, Shares of BreitBurn Energy Partners L.P. (NASDAQ:BBEP), dropped -0.47%, and is now trading at $5.28.
BreitBurn Energy Partners, declared a cash distribution of $0.04166 per common unit for the third month attributable to the first quarter of 2015, payable on June 12, 2015, to record holders of its common units at the close of business on June 8, 2015. This monthly distribution is equal to a distribution of $0.50 per common unit on an annualized basis.
Breitburn also declared distributions for its 8.25% Series A Cumulative Redeemable Perpetual Preferred Units (BBEPP) and 8.0% Series B Perpetual Convertible Preferred Units. A cash distribution of $0.171875 per Series A Unit, is payable on July 15, 2015, to record holders of its Series A Units at the close of business on June 30, 2015. This monthly distribution is equal to an annual distribution of $2.0625 per Series A Unit. Breitburn has elected to pay the distribution on the Series B Units in kind by issuing additional Series B Units instead of paying a cash distribution. A distribution of 0.006666 PIK unit per Series B Unit is payable on June 15, 2015, to record holders of Series B Units at the close of business on May 29, 2015.
Breitburn Energy Partners LP, an independent oil and gas partnership, acquires, exploits, and develops oil, natural gas liquids (NGLs), and natural gas properties in the United States.
During an Afternoon trade, Shares of Signal Genetics Inc (NASDAQ:SGNL), dipped -6.86%, and is now trading at $1.90.
Signal Genetics, declared that Samuel D. Riccitelli, President and Chief Executive Officer of Signal, will present a corporate overview at the LD Micro Invitational on June 1, 2015.
Signal Genetics, Inc., headquartered in Carlsbad, California, is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that assist physicians make better-informed decisions concerning the care of their patients suffering from cancer. Signal’s mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions. Signal was founded in January 2010 and became the exclusive licensee in its licensed field to the renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences, in April 2010.
Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer.
Shares of Baidu Inc (ADR) (NASDAQ:BIDU), during its Friday’s current trading session fell - 0.67%, and is now trading at $198.84.
Baidu, declared a multi-million dollar planned investment partnership with Baidu Inc. (BIDU), the leading Chinese language Internet search provider. The partnership brings together two cutting-edge technology companies that are re-defining the “search” and “discovery” categories across the world`s biggest markets. Together, Taboola and Baidu plan to bring discovery to the Chinese market, where mobile is the number one way people go online.
The investment from Baidu is a follow-on to the $117 million Series E round of financing declared by Taboola this past February, and represents another noteworthy vote of confidence in Taboola and the future of content discovery. Baidu ranks as the top website in China, and fourth most popular in the world (according to global traffic ranking firm Alexa), receiving tens of billions of search queries every day, about 75 percent of China`s combined PC and mobile search market share.
Baidu, Inc. provides Internet search services in China and internationally. It offers Chinese language search platform on its Baidu.com Website that enables users to find relevant information online, counting Web pages, news, images, documents, and multimedia files through links offered on its Website; and international products and services to users in other countries.
Finally, Berkshire Hathaway Inc. (NYSE:BRK.B), lost -0.80% Friday.
A.M. Best has affirmed the financial strength rating of A++ (Superior) and the issuer credit rating of “aa+” of members of the MedPro Group (MedPro) (headquartered in Fort Wayne, IN).
The ratings apply to The Medical Protective Company (Fort Wayne, IN), its associate, Princeton Insurance Company (Princeton, NJ) and its two reinsured associates, MedPro RRG Risk Retention Group and AttPro RRG Reciprocal Risk Retention Group (both domiciled in the District of Columbia). The outlook for all ratings is stable.
These ratings reflect MedPro’s excellent balance sheet strength, its favorable long-term operating performance and the noteworthy market position it maintains in the medical professional liability line of business. The ratings also consider the group’s substantial distribution capabilities and aggressive claims handling philosophy. Furthermore, these ratings continue to benefit from the implicit and explicit support offered by MedPro’s ultimate parent, Berkshire Hathaway Inc. (Berkshire), which comprises reinsurance programs, investment opportunities and capital support.
Berkshire Hathaway, Inc. is a publicly owned investment manager. Through its auxiliaries, the firm primarily engages in the insurance and reinsurance of property and casualty risks business. Berkshire Hathaway was founded in 1889 and is based in Omaha, Nebraska.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
